Literature DB >> 10188249

Ferric-reductase activities in Vibrio vulnificus biotypes 1 and 2.

R Mazoy1, E M Lopez, B Fouz, C Amaro, M L Lemos.   

Abstract

In this paper, the ferric-reductase activities of Vibrio vulnificus were investigated. This species comprises two biotypes pathogenic for humans and eels that are able to express different mechanisms for iron acquisition. All strains of both biotypes used in this study were able to reduce ferric citrate, irrespective of the iron levels in the growth medium. Some variation in the degree of reduction was observed among the strains, with the highest values corresponding to one acapsulated environmental strain of biotype 1. When cell fractions were tested, only those from periplasm and cytoplasm showed reductase activity whereas no activity was detected in membranes. Low temperatures inhibited these activities in both whole cells and cell fractions. At least six bands with ferric-reductase activity were identified in all strains using native polyacrylamide gels. These data demonstrate that the two biotypes of V. vulnificus produce similar ferric-reductases mainly located in the periplasm and cytoplasm and these could be involved in iron acquisition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188249     DOI: 10.1111/j.1574-6968.1999.tb13470.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

Review 1.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 2.  Vibrio Iron Transport: Evolutionary Adaptation to Life in Multiple Environments.

Authors:  Shelley M Payne; Alexandra R Mey; Elizabeth E Wyckoff
Journal:  Microbiol Mol Biol Rev       Date:  2015-12-09       Impact factor: 11.056

3.  A novel ferric reductase purified from Magnetospirillum gryphiswaldense MSR-1.

Authors:  Meng Xia; Jiang Wei; Yang Lei; Li Ying
Journal:  Curr Microbiol       Date:  2007-05-28       Impact factor: 2.188

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.